DOJ Progenity Resolves US DOJ Billing, Past Practice Investigations for $35.8M Along with the federal settlement, the company will also pay an additional $13.2 million to settle civil claims by different state attorneys general. Agendia Settles Allegations of Medicare Fraud for $8.25M The US DOJ alleged that the company conspired to "artificially delay" ordering its MammaPrint test in order to circumvent Medicare's 14-day rule. UTC Labs, Principals Agree to Pay $42.6M in PGx Testing Fraud Case According to the DOJ, the company also accepted a 25-year ban on participating in any federal healthcare program. Myriad Genetics Settles Improper Medicare Billing Complaint for $9.1M The company decided to settle the complaint in order to avoid "lengthy and distracting litigation," but denies any wrongdoing. Former Illumina Accountant Pleads Guilty to Insider Trading Martha Bustos allegedly helped a friend gain millions by tipping him off with confidential information in advance of Illumina's quarterly reports. Breaking News Illumina, Kartos Therapeutics Partner to Develop TP53 Companion Diagnostic Genomic Effects of Radiation From Chernobyl Nuclear Disaster Examined in New Studies Medicare Administrative Contractor Palmetto Finalizes Coverage of Molecular Testing for Organ Transplant Rejection 23andMe Team Sees Genetic, Nongenetic Contributors to COVID-19 Risk in Trans-Ancestry Study Todos Medical Acquires Provista Diagnostics for $7.5M Renalytix AI Lands US Government Contract for Kidney Disease Test The Scan Not Kept "Clean and Sanitary" A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports. Resumption Recommendation Expected The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine. Canada's New Budget on Science Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research. Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.